semaglutide safety Efficacy and of 2.4 mg by race and ethnicity: A post hoc analysis of three randomized controlled trials - Rubino - 2024 - Obesity Health regulators warn against the
Description
Jager J, Gremeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF
GLP-1 agonists slow stomach emptying, which increases aspiration risk during anesthesia
Tirzepatide may offer similar protection by lowering inflammation that contributes to joint destruction in arthritis
Use of incretin agents and risk of pancreatic cancer: a population-based cohort study
Can the Precision Peptide Genetic Test predict whether I'll respond to semaglutide
Many patients find long-term maintenance at a lower compounded dose ($149$189/mo) more sustainable than full discontinuation, preserving weight-loss results indefinitely
